GGrantIndex
Sort

64,565 grants matching drug discovery

Correlation of Quantum Dot Photophysics and Structure with Atomic Precision

$495,000
Sandra J Rosenthal · Vanderbilt University · · FY2012 · MPS

mRNA Capping Enzymes

$494,998
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM

Kentucky Center for Clinical and Translational Science

$494,989
Philip A Kern · University Of Kentucky · KL2 · FY2014 · TR

ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY

$494,954
Scott Charles Baraban · University Of California, San Francisco · R01 · FY2024 · NS

Optically Promoting Cardiac Maturation Using Engineered Peptides

$494,946
Herdeline Ann Mallari Ardoã‘a · University Of California-Irvine · R56 · FY2022 · HL

Patterning myocardial specification of human pluripotent stem cells

$494,892
Hee Cheol Cho · Johns Hopkins University · R01 · FY2022 · HL

Viral and Bacterial DNA Ligases

$494,856
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM

Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors

$494,843
Elizabeth Ann Coleman · Univ Of Arkansas For Med Scis · RC2 · FY2010 · NR

Study and Treatment of Mitochondrial DNA Depletion Syndrome 3 Using iPSCs

$494,836
Stephen A Duncan · Medical University Of South Carolina · R01 · FY2020 · DK

Study and Treatment of Mitochondrial DNA Depletion Syndrome 3 Using iPSCs

$494,836
Stephen A Duncan · Medical University Of South Carolina · R01 · FY2021 · DK

Study and Treatment of Mitochondrial DNA Depletion Syndrome 3 Using iPSCs

$494,836
Stephen A Duncan · Medical University Of South Carolina · R01 · FY2019 · DK

Study and Treatment of Mitochondrial DNA Depletion Syndrome 3 Using iPSCs

$494,836
Stephen A Duncan · Medical University Of South Carolina · R01 · FY2022 · DK

Enzymes: Structure, Mechanism, Function and Inhibition

$494,832
Debra Dunaway-Mariano · University Of New Mexico · R01 · FY2008 · GM

ID. of Pathways that can be Targeted for the Develop. of Novel Therapies for MRSA

$494,763
Eleftherios Mylonakis · Massachusetts Eye And Ear Infirmary · P01 · FY2011 · AI

SYNTHESIS OF ANTICANCER AGENTS

$494,739
K. C. Nicolaou · Scripps Research Institute, The · R01 · FY2008 · CA

Recyclable Magnetic Co/C Hybrid ROMP Reagents, Scavengers and Ligands

$494,726
Paul R. Hanson · Materia, Inc. · R42 · FY2015 · GM

Viral and Bacterial DNA Ligases

$494,671
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2012 · GM

Viral and Bacterial DNA Ligases

$494,671
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2011 · GM

An automated high throughput phenotypic screen for schistosomiasis drug discovery

$494,669
Conor Caffrey · University Of California, San Francisco · R01 · FY2010 · AI

Subtype Selective GABAA Receptor Modulators for the Treatment of Dravet Syndrome

$494,651
Jed L Hubbs · Neurocycle Therapeutics, Inc. · R43 · FY2019 · NS

High Performance Clustered Storage for Image Management

$494,553
Peter Karl Sorger · Harvard Medical School · S10 · FY2010 · RR

Protein Structure, Stability, and Amyloid Formation

$494,510
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Molecular and Genetic Analysis of Lung Cancer Survival

$494,502
David C Christiani · Harvard School Of Public Health · R01 · FY2013 · CA

Rational Design of antivrials targeted to HIV-1 capsid

$494,502
Asim K Debnath · New York Blood Center · R01 · FY2013 · AI

Training Grant on Alzheimer's Disease and ADRD at Indiana University

$494,484
Gary E. Landreth · Indiana University Indianapolis · T32 · FY2022 · AG